LONA

News Athira (ATHA) Q2 Loss Narrows 74%

14d ago

News Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up - Zacks Investment Research

14d ago

SEC filing LONA Approves 2026 Equity Plan, Terminates 2020 Plan, 5.5M Shares from Sermonix Pre-Funded Warrant Exercise

75d ago

Insider trade Sale by Robert Renninger (CHIEF FINANCIAL OFFICER)

88d ago

Insider trade Sale by Mark James Litton (PRESIDENT and CEO)

88d ago

Insider trade Sale by Mark Worthington (GENERAL COUNSEL and CCO)

88d ago

Insider trade Sale by Kevin Church (CHIEF SCIENTIFIC OFFICER)

88d ago

Insider trade Sale by Martin Javier San (CHIEF MEDICAL OFFICER)

88d ago

Scanner Unusual volume (2.2x average)

125d ago

News Tanabe Pharma America Announces Positive Topline Results for Dersimelagon in Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP)

133d ago

News AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca

134d ago